CD276 anticorps (AA 100-300)
Aperçu rapide pour CD276 anticorps (AA 100-300) (ABIN7859002)
Antigène
Voir toutes CD276 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 100-300
-
Fonction
- CD276 / B7-H3 Antibody
-
Specificité
- T cell activation and immune function are regulated by the innate immune system through positive and negative costimulatory molecules. One such molecule, B7-H3 (B7-homolog 3, also designated B7RP-2) belongs to the B7 immunoglobulin superfamily. Soluble B7-H3 binds a putative receptor on activated T-cells that is distinct from CD28, CTLA-4, ICOS and PD-1. Widely expressed on nonlymphoid tissues, B7-H3 costimulates proliferation of both CD4+ and CD8+ T cells. The ability of B7-H3 to stimulate Th1 and cytotoxic-T cell responses suggest that it may have antitumor activity. B7-H3 interactions may play a role in regulating cell-mediated immune responses against cancer, implicating B7-H3 as a potential therapeutic tool.
-
Purification
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogène
- Recombinant fragment (around aa100-300) of human CD276 protein (exact sequence is proprietary)
-
Isotype
- IgG1, kappa
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Agent conservateur
- Azide free
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- CD276
-
Autre désignation
- CD276
-
Sujet
-
4Ig B7 H3, B7 homolog 3, B7-H3, B7H3, B7RP-2, CD276, CD276 antigen, CD276 Molecule, Costimulatory molecule
hepatocellular carcinoma or lung carcinoma.|Human tonsil|Placenta
-
Poids moléculaire
- B7-H3 isoforms: 57/34/53/57 kDa, glycosylated B7-H3: 90-110 kDa
-
ID gène
- 80381, 77873
-
UniProt
- Q5ZPR3
-
Pathways
- Cancer Immune Checkpoints
Antigène
-